LncRNAs Associated with Chemoradiotherapy Response and Prognosis in Locally Advanced Rectal Cancer

References

• Heald RJ, Husband EM, Ryall RD. The mesorectum in rectal cancer surgery–the clue to pelvic recurrence. Br J Surg. 1982;69:613–616. doi:10.1002/bjs.1800691019
   PubMed Web of Science ®Google Scholar
• Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351(17):1731–1740. doi:10.1056/NEJMoa040694
   PubMed Web of Science ®Google Scholar
• Sauer R, Liersch T, Merkel S, et al. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized Phase III trial after a median follow-up of 11 years. J Clin Oncol. 2012;30(16):1926–1933. doi:10.1200/JCO.2011.40.1836
   PubMed Web of Science ®Google Scholar
• van Gijn W, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol. 2011;12(6):575–582. doi:10.1016/S1470-2045(11)70097-3
   PubMed Web of Science ®Google Scholar
• Ha YJ, Tak KH, Kim CW, et al. PSMB8 as a candidate marker of responsiveness to preoperative radiation therapy in rectal cancer patients. Int J Radiat Oncol Biol Phys. 2017;98(5):1164–1173. doi:10.1016/j.ijrobp.2017.03.023
   PubMed Web of Science ®Google Scholar
• Ling H, Fabbri M, Calin GA. MicroRNAs and other non-coding RNAs as targets for anticancer drug development. Nat Rev Drug Discov. 2013;12:847–865. doi:10.1038/nrd4140
   PubMed Web of Science ®Google Scholar
• Anderson DM, Anderson KM, Chang CL, et al. A micropeptide encoded by a putative long noncoding RNA regulates muscle performance. Cell. 2015;160:595–606. doi:10.1016/j.cell.2015.01.009
   PubMed Web of Science ®Google Scholar
• Fatica A, Bozzoni I. Long non-coding RNAs: new players in cell differentiation and development. Nat Rev Genet. 2014;15:7–21. doi:10.1038/nrg3606
   PubMed Web of Science ®Google Scholar
• Nelson BR, Makarewich CA, Anderson DM, et al. A peptide encoded by a transcript annotated as long noncoding RNA enhances SERCA activity in muscle. Science. 2016;351:271–275. doi:10.1126/science.aad4076
   PubMed Web of Science ®Google Scholar
• Dai W, Feng Y, Mo S, et al. Transcriptome profiling reveals an integrated mRNA-lncRNA signature with predictive value of early relapse in colon cancer. Carcinogenesis. 2018;39:1235–1244. doi:10.1093/carcin/bgy087
   PubMed Web of Science ®Google Scholar
• Fernández-Barrena MG, Perugorria MJ, Banales JM. Novel lncRNA T-UCR as a potential downstream driver of the Wnt/β-catenin pathway in hepatobiliary carcinogenesis. Gut. 2017;66:1177–1178. doi:10.1136/gutjnl-2016-312899
   PubMed Web of Science ®Google Scholar
• Li W, Zhang Z, Liu X, et al. The FOXN3-NEAT1-SIN3A repressor complex promotes progression of hormonally responsive breast cancer. J Clin Invest. 2017;127:3421–3440. doi:10.1172/JCI94233
   PubMed Web of Science ®Google Scholar
• Shi L, Hong X, Ba L, et al. Long non-coding RNA ZNFX1-AS1 promotes the tumor progression and metastasis of colorectal cancer by acting as a competing endogenous RNA of miR-144 to regulate EZH2 expression. Cell Death Dis. 2019;10:150. doi:10.1038/s41419-019-1332-8
   PubMed Web of Science ®Google Scholar
• Ali MM, Akhade VS, Kosalai ST, et al. PAN-cancer analysis of S-phase enriched lncRNAs identifies oncogenic drivers and biomarkers. Nat Commun. 2018;9:883. doi:10.1038/s41467-018-03265-1
   PubMed Web of Science ®Google Scholar
• Casero D, Sandoval S, Seet CS, et al. Long non-coding RNA profiling of human lymphoid progenitor cells reveals transcriptional divergence of B cell and T cell lineages. Nat Immunol. 2015;16:1282–1291. doi:10.1038/ni.3299
   PubMed Web of Science ®Google Scholar
• Fu X, Ravindranath L, Tran N, Petrovics G, Srivastava S. Regulation of apoptosis by a prostate-specific and prostate cancer-associated noncoding gene, PCGEM1. DNA Cell Biol. 2006;25:135–141. doi:10.1089/dna.2006.25.135
   PubMed Web of Science ®Google Scholar
• Jiang Z, Slater CM, Zhou Y, et al. LincIN, a novel NF90-binding long non-coding RNA, is overexpressed in advanced breast tumors and involved in metastasis. Breast Cancer Res. 2017;19:62. doi:10.1186/s13058-017-0853-2
   PubMed Web of Science ®Google Scholar
• Kurian L, Aguirre A, Sancho-Martinez I, et al. Identification of novel long noncoding RNAs underlying vertebrate cardiovascular development. Circulation. 2015;131:1278–1290. doi:10.1161/CIRCULATIONAHA.114.013303
   PubMed Web of Science ®Google Scholar
• Sánchez Y, Huarte M. Long non-coding RNAs: challenges for diagnosis and therapies. Nucleic Acid Ther. 2013;23:15–20. doi:10.1089/nat.2012.0414
   PubMed Web of Science ®Google Scholar
• Li P, Zhang X, Wang H, et al. MALAT1 is associated with poor response to oxaliplatin-based chemotherapy in colorectal cancer patients and promotes chemoresistance through EZH2. Mol Cancer Ther. 2017;16:739–751. doi:10.1158/1535-7163.MCT-16-0591
   PubMed Web of Science ®Google Scholar
• Li Z, Chen Y, Ren WU, et al. Transcriptome alterations in liver metastases of colorectal cancer after acquired resistance to cetuximab. Cancer Genomics Proteomics. 2019;16:207–219. doi:10.21873/cgp.20126
   PubMed Web of Science ®Google Scholar
• Yokoyama Y, Sakatani T, Wada R, et al. In vitro and in vivo studies on the association of long non‑coding RNAs H19 and urothelial cancer associated 1 with the susceptibility to 5‑fluorouracil in rectal cancer. Int J Oncol. 2019;55(6):1361–1371. doi:10.3892/ijo.2019.4895
   PubMed Web of Science ®Google Scholar
• Li N, Yu J, Luo A, et al. LncRNA and mRNA signatures associated with neoadjuvant chemoradiotherapy downstaging effects in rectal cancer. J Cell Biochem. 2019;120:5207–5217. doi:10.1002/jcb.27796
   PubMed Web of Science ®Google Scholar
• Ferrando L, Cirmena G, Garuti A, et al. Development of a long non-coding RNA signature for prediction of response to neoadjuvant chemoradiotherapy in locally advanced rectal adenocarcinoma. PLoS One. 2020;15(2):e0226595. doi:10.1371/journal.pone.0226595
   PubMed Web of Science ®Google Scholar
• Benitez JC, Campayo M, Díaz T, et al. Lincp21-RNA as predictive response marker for preoperative chemoradiotherapy in rectal cancer. J Pers Med. 2021;11(5). doi:10.3390/jpm11050420
   Web of Science ®Google Scholar
• Zhang Y, Sun Y, Xu Z, Chi P, Lu X. Is neoadjuvant chemoradiotherapy always necessary for mid/high local advanced rectal cancer: a comparative analysis after propensity score matching. Eur J Surg Oncol. 2017;43(8):1440–1446. doi:10.1016/j.ejso.2017.04.007
   PubMed Web of Science ®Google Scholar
• Benson AB, Venook AP, Al-Hawary MM, et al. Rectal cancer, version 2.2018, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2018;16(7):874–901. doi:10.6004/jnccn.2018.0061
   PubMed Web of Science ®Google Scholar
• Zerbino DR, Achuthan P, Akanni W, et al. Ensembl 2018. Nucleic Acids Res. 2018;46:D754–754D761. doi:10.1093/nar/gkx1098
   PubMed Web of Science ®Google Scholar
• Zhang Y, Sun L, Sun Y, et al. Overexpressed CES2 has prognostic value in CRC and knockdown CES2 reverses L-OHP-resistance in CRC cells by inhibition of the PI3K signaling pathway. Exp Cell Res. 2020;389:111856. doi:10.1016/j.yexcr.2020.111856
   PubMed Web of Science ®Google Scholar
• Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J Stat Softw. 2010;33(1):1–22. doi:10.18637/jss.v033.i01
   PubMed Web of Science ®Google Scholar
• Agesen TH, Sveen A, Merok MA, et al. ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis. Gut. 2012;61:1560–1567. doi:10.1136/gutjnl-2011-301179
   PubMed Web of Science ®Google Scholar
• Zhang JX, Song W, Chen ZH, et al. Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis. Lancet Oncol. 2013;14:1295–1306. doi:10.1016/S1470-2045(13)70491-1
   PubMed Web of Science ®Google Scholar
• Jiang Y, Zhang Q, Hu Y, et al. ImmunoScore signature: a prognostic and predictive tool in gastric cancer. Ann Surg. 2018;267:504–513. doi:10.1097/SLA.0000000000002116
   PubMed Web of Science ®Google Scholar
• Sveen A, Ågesen TH, Nesbakken A, et al. ColoGuidePro: a prognostic 7-gene expression signature for stage III colorectal cancer patients. Clin Cancer Res. 2012;18:6001–6010. doi:10.1158/1078-0432.CCR-11-3302
   PubMed Web of Science ®Google Scholar
• Rousson V, Zumbrunn T. Decision curve analysis revisited: overall net benefit, relationships to ROC curve analysis, and application to case-control studies. BMC Med Inform Decis Mak. 2011;11:45. doi:10.1186/1472-6947-11-45
   PubMed Web of Science ®Google Scholar
• Vickers AJ, Elkin EB. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making. 2006;26:565–574. doi:10.1177/0272989X06295361
   PubMed Web of Science ®Google Scholar
• Alidoust M, Hamzehzadeh L, Rivandi M, et al. Polymorphisms in non-coding RNAs and risk of colorectal cancer: a systematic review and meta-analysis. Crit Rev Oncol Hematol. 2018;132:100–110. doi:10.1016/j.critrevonc.2018.09.003
   PubMed Web of Science ®Google Scholar
• Pichler M, Rodriguez-Aguayo C, Nam SY, et al. Therapeutic potential of FLANC, a novel primate-specific long non-coding RNA in colorectal cancer. Gut. 2020;69:1818–1831. doi:10.1136/gutjnl-2019-318903
   PubMed Web of Science ®Google Scholar
• Wei L, Wang X, Lv L, et al. The emerging role of noncoding RNAs in colorectal cancer chemoresistance. Cell Oncol (Dordr). 2019;42(6):757–768. doi:10.1007/s13402-019-00466-8
   PubMed Web of Science ®Google Scholar
• Liu Z, Lu C, Hu H, et al. LINC00909 promotes tumor progression in human glioma through regulation of miR-194/MUC1-C axis. Biomed Pharmacother. 2019;116:108965. doi:10.1016/j.biopha.2019.108965
   PubMed Web of Science ®Google Scholar
• Xu W, Zhou G, Wang H, et al. Circulating lncRNA SNHG11 as a novel biomarker for early diagnosis and prognosis of colorectal cancer. Int J Cancer. 2019. doi:10.1002/ijc.32747
   Web of Science ®Google Scholar
• Lee M, Kwon DY, Kim MS, Choi CR, Park MY, Kim AJ. Genome-wide association study for the interaction between BMR and BMI in obese Korean women including overweight. Nutr Res Pract. 2016;10:115–124. doi:10.4162/nrp.2016.10.1.115
   PubMed Web of Science ®Google Scholar
• Ahmad S, Zhao W, Renström F, et al. A novel interaction between the FLJ33534 locus and smoking in obesity: a genome-wide study of 14 131 Pakistani adults. Int J Obes (Lond). 2016;40:186–190. doi:10.1038/ijo.2015.152
   PubMed Web of Science ®Google Scholar
• Kopp F, Mendell JT. Functional classification and experimental dissection of long noncoding RNAs. Cell. 2018;172:393–407. doi:10.1016/j.cell.2018.01.011
   PubMed Web of Science ®Google Scholar
• Fan CN, Ma L, Liu N. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer. J Transl Med. 2018;16:264. doi:10.1186/s12967-018-1640-2
   PubMed Web of Science ®Google Scholar
• Bando H, Kagawa Y, Kato T, et al. Correction: a multicentre, prospective study of plasma circulating tumour DNA test for detecting RAS mutation in patients with metastatic colorectal cancer. Br J Cancer. 2020;122:1271. doi:10.1038/s41416-020-0766-1
   PubMed Web of Science ®Google Scholar
• Samalin E, Mazard T, Assenat E, et al. Triplet chemotherapy plus cetuximab as first-line treatment in RAS wild-type metastatic colorectal carcinoma patients. Ann Oncol. 2019;30(Suppl 4):iv26–26iv27. doi:10.1093/annonc/mdz155.098
   Google Scholar
• Vera R, Mata E, González E, et al. Is aflibercept an optimal treatment for wt RAS mCRC patients after progression to first line containing anti-EGFR. Int J Colorectal Dis. 2020;35:739–746. doi:10.1007/s00384-020-03509-x
   PubMed Web of Science ®Google Scholar
• Gu J, Zhang X, Miao R, et al. A three-long non-coding RNA-expression-based risk score system can better predict both overall and recurrence-free survival in patients with small hepatocellular carcinoma. Aging (Albany NY). 2018;10(7):1627–1639. doi:10.18632/aging.101497
   PubMedGoogle Scholar
• Liao M, Liu Q, Li B, et al. A group of long noncoding RNAs identified by data mining can predict the prognosis of lung adenocarcinoma. Cancer Sci. 2018;109(12):4033–4044. doi:10.1111/cas.13822
   PubMed Web of Science ®Google Scholar
• Liu Q, Luo D, Cai S, Li Q, Li X. Real-world implications of nonbiological factors with staging, prognosis and clinical management in colon cancer. Cancers (Basel). 2018;10:263. doi:10.3390/cancers10080263
   PubMed Web of Science ®Google Scholar
• Zhou R, Zeng D, Zhang J, et al. A robust panel based on tumour microenvironment genes for prognostic prediction and tailoring therapies in stage I-III colon cancer. EBioMedicine. 2019;42:420–430. doi:10.1016/j.ebiom.2019.03.043
   PubMed Web of Science ®Google Scholar
• Benson AB, Venook AP, Cederquist L, et al. Colon cancer, version 1.2017, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2017;15:370–398. doi:10.6004/jnccn.2017.0036
   PubMed Web of Science ®Google Scholar
• Ackermann CJ, Guller U, Jochum W, Schmied BM, Warschkow R. The prognostic value of signet ring cell histology in stage I/II colon cancer-A population-based, propensity score-matched analysis. Int J Colorectal Dis. 2018;33:1183–1193. doi:10.1007/s00384-018-3096-5
   PubMed Web of Science ®Google Scholar
• Low YS, Blöcker C, McPherson JR, et al. A formalin-fixed paraffin-embedded (FFPE)-based prognostic signature to predict metastasis in clinically low risk stage I/II microsatellite stable colorectal cancer. Cancer Lett. 2017;403:13–20. doi:10.1016/j.canlet.2017.05.031
   PubMed Web of Science ®Google Scholar